Teva Pharmaceutical Industries Limited Price to Earnings Ratio (PE) Ratios, (TEVA) Valuation Ranking and Trends, Fundamental Ratios - CSIMarket
CSIMarket
 




Teva Pharmaceutical Industries Limited  (NYSE: TEVA)
 





TEVA Price to Earnings Ratio Current (Dec 31 2025) (Sep 30 2025) (Jun 30 2025) (Mar 31 2025)
Diluted EPS 12 Trailing Months IV. Quarter III. Quarter II. Quarter I. Quarter
PE (TTM) Ratio current            29.52            20.31            28.91            28.91            28.91
Diluted EPS TTM Y / Y Change - % - % - % -62.09 % 166.41 %
Diluted EPS Y / Y Change 69.56 % - % - % - % - %
Stock performance to date 27.95 % 55.58 % 21.39 % 9.61 % -27.84 %

Price to earnings ratio Comment
Teva Pharmaceutical Industries Limited's current Price to earnings ratio has increased due to shareprice growth of 27.95 %, from beginning of I. Quarter and despite eps increase of 69.56 %, to Pe of 29.52, from average Price to earnings ratio in IV. Quarter of 20.31.

Within Healthcare sector 153 other companies have lower Price to earnings ratio.

What is Price to Earnings Ratio?
What is Teva Pharmaceutical Industries Limited Market Share?

Price to earnings ratio Company Ranking
Within: No.
Industry #67
Sector #154
S&P 500 #1828





Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.